Business Description
Supriya Lifescience Ltd
ISIN : INE07RO01027
Total Employee Number:
1,071Compare
Compare
Traded in other countries / regions
543434.India IPO Date
2021-12-28Description
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 14.51 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 140.62 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 26.75 | |||||
Beneish M-Score | -1.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.4 | |||||
3-Year EBITDA Growth Rate | 30.6 | |||||
3-Year EPS without NRI Growth Rate | 31.6 | |||||
3-Year Book Growth Rate | 19.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.95 | |||||
9-Day RSI | 38.74 | |||||
14-Day RSI | 42.26 | |||||
3-1 Month Momentum % | 44.9 | |||||
6-1 Month Momentum % | 34.19 | |||||
12-1 Month Momentum % | 37.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.4 | |||||
Quick Ratio | 3.08 | |||||
Cash Ratio | 0.65 | |||||
Days Inventory | 201.52 | |||||
Days Sales Outstanding | 74.79 | |||||
Days Payable | 125.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.12 | |||||
Dividend Payout Ratio | 0.04 | |||||
3-Year Dividend Growth Rate | 18.6 | |||||
Forward Dividend Yield % | 0.12 | |||||
5-Year Yield-on-Cost % | 0.12 | |||||
Shareholder Yield % | 0.12 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.32 | |||||
Operating Margin % | 32.09 | |||||
Net Margin % | 25.26 | |||||
EBITDA Margin % | 36.85 | |||||
FCF Margin % | 4.05 | |||||
OCF Margin % | 22.44 | |||||
ROE % | 19.15 | |||||
ROA % | 17.08 | |||||
ROIC % | 19.28 | |||||
3-Year ROIIC % | 20.87 | |||||
ROC (Joel Greenblatt) % | 28.78 | |||||
ROCE % | 24.51 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 32.06 | |||||
Forward PE Ratio | 27.28 | |||||
PE Ratio without NRI | 32 | |||||
Price-to-Owner-Earnings | 47.27 | |||||
PS Ratio | 8.1 | |||||
PB Ratio | 5.6 | |||||
Price-to-Tangible-Book | 5.6 | |||||
Price-to-Free-Cash-Flow | 199.91 | |||||
Price-to-Operating-Cash-Flow | 36.08 | |||||
EV-to-EBIT | 23.95 | |||||
EV-to-EBITDA | 21.72 | |||||
EV-to-Revenue | 8.01 | |||||
EV-to-FCF | 196.69 | |||||
Price-to-GF-Value | 1.02 | |||||
Price-to-Projected-FCF | 6.39 | |||||
Price-to-Graham-Number | 2.82 | |||||
| Price-to-Net-Current-Asset-Value | 17.97 | |||||
Earnings Yield (Greenblatt) % | 4.17 | |||||
FCF Yield % | 0.49 | |||||
Forward Rate of Return (Yacktman) % | -5.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Supriya Lifescience Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 8,278.75 | ||
| EPS (TTM) (₹) | 25.98 | ||
| Beta | 1.23 | ||
| 3-Year Sharpe Ratio | 1.09 | ||
| 3-Year Sortino Ratio | 2.58 | ||
| Volatility % | 52.27 | ||
| 14-Day RSI | 42.26 | ||
| 14-Day ATR (₹) | 40.21118 | ||
| 20-Day SMA (₹) | 891.0175 | ||
| 12-1 Month Momentum % | 37.31 | ||
| 52-Week Range (₹) | 545.5 - 1085 | ||
| Shares Outstanding (Mil) | 80.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Supriya Lifescience Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Supriya Lifescience Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-13 11:00 | In 113 days | ||
| Second quarter earnings results for 2027 | 2026-11-13 | In 112 days | ||
| General meeting for 2026 | 2026-09-24 15:00 | In 63 days | ||
| Annual report for 2026 | 2026-09-01 | In 39 days | ||
| First quarter earnings conference call for 2027 | 2026-08-14 11:00 | In 22 days | ||
| First quarter earnings results for 2027 | 2026-08-14 | In 21 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-28 11:00 | 807.25 (+2.31%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-28 | 807.25 (+2.31%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-10 11:00 | 687.90 (+2.79%) | ||
| Third quarter earnings results for 2026 | 2026-02-10 | 687.90 (+2.79%) |
Show
Entries
Supriya Lifescience Ltd Frequently Asked Questions
What is Supriya Lifescience Ltd(NSE:SUPRIYA)'s stock price today?
The current price of NSE:SUPRIYA is ₹832.90. The 52 week high of NSE:SUPRIYA is ₹1085.00 and 52 week low is ₹545.50.
When is next earnings date of Supriya Lifescience Ltd(NSE:SUPRIYA)?
The next earnings date of Supriya Lifescience Ltd(NSE:SUPRIYA) is 2026-08-14 Est..
Does Supriya Lifescience Ltd(NSE:SUPRIYA) pay dividends? If so, how much?
The Dividend Yield %  of Supriya Lifescience Ltd(NSE:SUPRIYA) is 0.12% (As of Today), Highest Dividend Payout Ratio of Supriya Lifescience Ltd(NSE:SUPRIYA) was 0.05. The lowest was 0.03. And the median was 0.04. The  Forward Dividend Yield % of Supriya Lifescience Ltd(NSE:SUPRIYA) is 0.12%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Supriya Lifescience Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers